> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# IntraBio Wins Priority Voucher for Aqneursa Approval
- URL: https://www.fdaweb.com/intrabio-wins-priority-voucher-for-aqneursa-approval/
- Published: 2024-10-15T12:00:00.000Z
- Updated: 2026-09-14T14:44:00.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157983

*Federal Register* notice: FDA is announcing that it issued IntraBio a priority review voucher after determining its recent approval of Aqneursa (levacetylleucine), indicated for treating Niemann-Pick disease Type C in adults and pediatric patients, met the voucher criteria for issuance. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-10-15/pdf/2024-23712.pdf?ref=fdaweb.com).